Literature DB >> 9493596

Microvesicles bind soluble fibrinogen, adhere to immobilized fibrinogen and coaggregate with platelets.

P A Holme1, N O Solum, F Brosstad, T Pedersen, M Kveine.   

Abstract

In the present study we have investigated whether platelet derived microvesicles can bind soluble fibrinogen, bind to immobilized fibrinogen, and coaggregate with platelets. Flow cytometry was used for studies on binding of soluble fibrinogen and coaggregation, whereas ELISA wells were used to study binding of microvesicles to immobilized fibrinogen. Biotinylated microvesicles produced by stimulation with A23187, thrombin or SFLLRN of platelets which had been surface-labelled with biotin, were used both for the coaggregation experiments and for the binding studies with immobilized fibrinogen. Unlabelled microvesicles and biotinylated fibrinogen were employed when studying binding of soluble fibrinogen to the microvesicles. For the flow cytometry, the biotinylated proteins were reacted with avidin or streptavidin which was PE-conjugated, whereas the same substances were conjugated with alkaline phosphatase for the ELISA studies. The microvesicles formed after stimulation of platelets by SFLLRN or A23187 clearly bound the soluble, biotinylated fibrinogen. Moreover, isolated biotinylated microvesicles added to washed platelets prior to activation, were associated to the microaggregates that formed after stimulation. A significant binding of biotinylated microvesicles to immobilized fibrinogen could also be detected. The binding of microvesicles to soluble and immobilized fibrinogen and association to platelets was clearly specific and at least partly dependent on the GPIIb-IIIa complex, as all of these phenomena could be prevented or reduced by addition of the c7E3 Fab which blocks the activated form of this receptor complex. From these in vitro results it is clear that microvesicles can bind to immobilized fibrinogen, bind soluble fibrinogen and are able to coaggregate with platelets. It may be speculated that these results also reflect a haemostatic role of microvesicles in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9493596

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.

Authors:  V Combes; A C Simon; G E Grau; D Arnoux; L Camoin; F Sabatier; M Mutin; M Sanmarco; J Sampol; F Dignat-George
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

2.  Proteomic characteristics of circulating microparticles in patients with newly-diagnosed type 2 diabetes.

Authors:  Min-Dan Xu; Xian-Zheng Wu; Yun Zhou; Ying Xue; Ke-Qin Zhang
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

Review 3.  Vascular actions of estrogens: functional implications.

Authors:  Virginia M Miller; Sue P Duckles
Journal:  Pharmacol Rev       Date:  2008-06-25       Impact factor: 25.468

4.  Hemocompatibility of Inorganic Physical Vapor Deposition (PVD) Coatings on Thermoplastic Polyurethane Polymers.

Authors:  Juergen M Lackner; Wolfgang Waldhauser; Paul Hartmann; Franz Bruckert; Marianne Weidenhaupt; Roman Major; Marek Sanak; Martin Wiesinger; Daniel Heim
Journal:  J Funct Biomater       Date:  2012-04-17

5.  Distinct features of circulating microparticles and their relationship with disease activity in inflammatory bowel disease.

Authors:  Evangelos Voudoukis; Eleni-Kyriaki Vetsika; Konstantina Giannakopoulou; Konstantinos Karmiris; Angeliki Theodoropoulou; Aekaterini Sfiridaki; Vassilis Georgoulias; Gregorios A Paspatis; Ioannis E Koutroubakis
Journal:  Ann Gastroenterol       Date:  2016 Apr-Jun

Review 6.  The biology of extracellular vesicles with focus on platelet microparticles and their role in cancer development and progression.

Authors:  M Żmigrodzka; M Guzera; A Miśkiewicz; D Jagielski; A Winnicka
Journal:  Tumour Biol       Date:  2016-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.